h ttp : / / w w w . b j m i c r o b i o l . c o m . b r /
Short
communication
Detection
of
virulence
and
-lactamase
encoding
genes
in
Enterobacter
aerogenes
and
Enterobacter
cloacae
clinical
isolates
from
Brazil
Paola
Aparecida
Alves
Azevedo
a,
João
Pedro
Rueda
Furlan
a,
Mariana
Oliveira-Silva
a,
Rafael
Nakamura-Silva
a,
Carolina
Nogueira
Gomes
a,
Karen
Regina
Carim
Costa
b,
Eliana
Guedes
Stehling
a,
André
Pitondo-Silva
a,∗aUniversidadedeSãoPaulo,FaculdadedeCiênciasFarmacêuticasdeRibeirãoPreto,DepartamentodeAnálisesClínicas,Toxicológicase Bromatológicas,RibeirãoPreto,SP,Brazil
bUniversidadeFederaldoAmazonas,Manaus,AM,Brazil
a
r
t
i
c
l
e
i
n
f
o
Articlehistory:
Received2September2017
Accepted19April2018
Availableonline21May2018
AssociateEditor:ElizabethMarques
Keywords: Enterobactercloacae Enterobacteraerogenes Virulence Resistance
a
b
s
t
r
a
c
t
EnterobactercloacaeandE.aerogeneshavebeenincreasinglyreportedasimportant
oppor-tunisticpathogens.Inthisstudy,ahighprevalenceofmulti-drugresistantisolatesfrom
Brazil,harboringseveral-lactamaseencodinggeneswasfound.Severalvirulencegenes
wereobservedinE.aerogenes,contrastingwiththeE.cloacaeisolateswhichpresentednone.
©2018SociedadeBrasileiradeMicrobiologia.PublishedbyElsevierEditoraLtda.Thisis
anopenaccessarticleundertheCCBY-NC-NDlicense(http://creativecommons.org/
licenses/by-nc-nd/4.0/).
BacteriabelongingtotheEnterobactergenusaregram-negative
facultativeanaerobesandwidelydistributedinnature.Inthe
lastdecades,speciesofthegenusEnterobacterhavearoused
greaterconcern,sincetheyareincreasinglyassociatedwith
nosocomial infections, especially in immunocompromised
patients.1EnterobacterspeciesaremembersofESKAPE
(Ente-rococcusfaecium, Staphylococcus aureus, Klebsiellapneumoniae,
∗ Correspondingauthorat:DepartamentodeAnálisesClínicas,ToxicológicaseBromatológicas,FaculdadedeCiênciasFarmacêuticasde
RibeirãoPreto,UniversidadedeSãoPaulo(USP),RibeirãoPreto.Av.doCafé,s/n,MonteAlegre,RibeirãoPreto,SPCEP:14040-903,Brazil.
E-mail:andre@pitondo.com.br(A.Pitondo-Silva).
Acinetobacterbaumannii,Pseudomonasaeruginosaand
Enterobac-ter species) which are described as the leading cause of
nosocomial infections throughoutthe world.2,3 Among the
species,E.aerogenesandE.cloacaestandoutasopportunistic
pathogens,especiallyinpatientsonmechanicalventilation.4
Enterobactersp.,including E.aerogenesandE.cloacae
eas-ily acquire numerous genetic mobile elements containing
https://doi.org/10.1016/j.bjm.2018.04.009
1517-8382/©2018SociedadeBrasileiradeMicrobiologia.PublishedbyElsevierEditoraLtda.ThisisanopenaccessarticleundertheCC
resistanceandvirulencegenes,whichstronglycontributeto
theincreasedpathogenicityofthesebacteria.Thesespecies
are extended spectrum -lactamase producers and posses
intrinsicresistancetoampicillin,amoxicillin,first-generation
cephalosporinsandcefoxitin,duetotheproductionof
consti-tutiveAmpC-lactamase.ThusEnterobactersp.maydevelop
antimicrobialresistanceduringtreatment,limiting
therapeu-ticoptions.3,4
Although studies have been pointing to the increasing
prevalence of E. cloacae and. E. aerogenes as opportunistic
pathogens,frequentlyassociatedwithmultidrug-resistance,
littleisknownabouttheirvirulencemechanisms.1Therefore,
the aimof this study was to characterizeE. aerogenes and
E.cloacae clinical isolatesfrom Brazil regardingthe genetic
relationships, antimicrobial susceptibility profile, and the
presenceofvirulenceand-lactamaseencodinggenes.
Inthisstudyatotalof14Enterobacterisolateswereincluded,
beingeightE.cloacae(EC)andsixE.aerogenes(EA).Amongthe
isolates,sevenwere obtainedfrom malepatients, sixfrom
female patientsand onewas notinformed. These isolates
wereobtainedbetweenMarch2013toSeptember2016from
threeBraziliantertiaryhospitalslocatedindifferentregions:
thesoutheast(RibeirãoPretocity,SãoPaulostate),northeast
(Teresinacity,Piauístate)andthenorthregion(Manauscity,
Amazonasstate).Theseisolateswereobtainedfromdifferent
sourcessuchasurine,blood,analandnasalswabs,catheter
tip,oropharynxandgastrostomytube(Table1).
Bacteriaidentificationwereperformedbymatrix-assisted
laserdesorption–ionizationtimeofflightmassspectrometry
(MALDI-TOFMS) using the Vitek® MS system (bioMérieux,
Marcyl’Etoile,France),accordingtothemanufacturer’s
rec-ommendations.
Theantimicrobialsusceptibilitytestswereperformedby
disc diffusion in Mueller-Hinton Agar (Oxoid), as
recom-mendedbytheClinicalLaboratoryStandardsInstitute(CLSI).5
Thirty-two different antibiotic discs (Oxoid) were tested:
amikacin(30g),aztreonam(30g),cefaclor(30g),cefepime
(30g),cefixime(5g),cefotaxime(30g),ceftriaxone(30g),
ceftazidime (30g), cefuroxime (30g), ciprofloxacin (5g),
chloramphenicol (30g), doripenem (10g), doxycycline
(30g), ertapenem (10g), gentamicin (10g), imipenem
(10g),levofloxacin(5g),lomefloxacin(10g),meropenem
(10g),minocycline(30g),nalidixicacid(30g),
nitrofuran-toin(300g),norfloxacin(10g),ofloxacin(5g),
piperacillin-tazobactam(100/10g),streptomycin(10g),sulphonamide
(300g),tetracycline(30g),ticarcillin-clavulanate(75/10g),
trimethoprim (5g), tobramycin (10g) and
trimethoprim-sulfamethoxazole (1.25/23.75g). Thestrains E. coli ATCC®
25922 and ATCC® 35218,and Pseudomonasaeruginosa ATCC
27853 were used asquality controlfor these experiments.
Althoughcefuroximeisconsideredasintrinsicresistancefor
E.cloaceaeand E.aerogenesbythe CLSI,5 thisantibioticwas
addedinthestudybecauseitisrecommendedbyMagiorakos
etal.6forthesespecies.Theisolateswereclassifiedas
multi-drug resistant (MDR), extensively drug-resistant (XDR) and
pandrug-resistant(PDR),accordingtothecriteriaestablished
byMagiorakosetal.6Isolateswhichdidnotfittheprevious
definitionsweredesignatedasnotclassified(NC).
GenomicDNAwasextractedusingthephenol/chloroform
methodasdescribedbyCovoneetal.7Theconcentrationand
purity were determined usinga DS-11+Spectrophotometer
(DeNovix,USA).
PCRreactionswereperformedforthedetectionofthe
fol-lowing-lactamaseencodinggenes:blaCTX-M-Gp1,blaCTX-M-Gp2,
Table1–GeneraldatarelatingtosixE.aerogenes(EA)andeightE.cloacae(EC)isolatesfromthisstudy.
Isolate Dateofisolation Sex Age Source Resistanceprofile(non-susceptible)
EA01 05/15/2013 F 39 Urine LMX,EST,DOR,CFC,CFM,CRX,DOX,NIT,SUL,SUT
EA02 05/06/2013 F 66 Urine CFC,CFM,DOX,NIT,SUL,TRI
EA03 04/30/2016 F NI Urine EST,CFC,CFM,DOX,MIN,NIT,SUL,SUT,NAL
EA04 05/05/2016 M NI Blood EST,CFC,DOX,MIN,NIT,SUL,SUT,NAL
EA05 09/15/2016 M 33 Cathetertip CIP,LEV,LMX,NOR,OFX,AMI,EST,GEN,TOB,DOR,ERT,MPM,CAZ,
CFC,CFM,CPM,CRO,CRX,CTX,ATM,PIT,TAC,DOX,MIN,TET,NIT,
SUL,SUT,TRI,NAL
EA06 04/29/2013 M 57 Nasalswab LMX,AMI,EST,GEN,TOB,DOR,ERT,IPM,CAZ,CPM,CRX,PIT,DOX,
NIT,SUL,SUT,TRI,NAL
EC01 04/20/2013 F NI Urine CFC,CFM,DOX,MIN,NIT,SUL,TRI,NAL
EC02 05/20/2013 F 57 Urine AMI,ERT,MPM,CFC,CFM,CRO,DOX,MIN,NIT,SUL,TRI,NAL
EC03 05/07/2016 NI NI Urine CIP,LEV,LMX,NOR,OFX,EST,TOB,CAZ,CFC,CFM,CPM,CRO,CRX,
CTX,ATM,PIT,TAC,DOX,MIN,TET,NIT,SUL,SUT,TRI,NAL
EC04 04/29/2013 F 43 Analswab CIP,LEV,LMX,NOR,OFX,EST,GEN,TOB,ERT,CAZ,CFC,CFM,CPM,
CRO,CRX,CTX,ATM,PIT,TAC,DOX,TET,NIT,SUL,SUT,TRI,CLO,NAL
EC05 05/06/2013 M 65 Analswab LMX,OFX,AMI,EST,GEN,ERT,CAZ,CFC,CFM,CPM,CRO,CRX,CTX,
ATM,PIT,TAC,SUL,SUT,TRI,NAL
EC06 02/23/2015 F 53 Oropharynx EST,CFC,CFM,CRX,DOX,NIT,SUL,SUT,TRI,NAL
EC07 03/13/2015 M 58 Cathetertip ERT,SUL,SUT,TRI
EC08 05/13/2015 M 51 Gastrostomytube CFC,CRX,NIT,SUL,SUT
Note:F,female;M,male,NI,not informed;AMI,amikacin;ATM,aztreonam;CFC,cefaclor; CPM,cefepime,CFM,cefixime;CRO,
ceftriax-one;CAZ,ceftazidime;CTX,cefotaxime;CRX,cefuroxime;CIP,ciprofloxacin;CLO,chloramphenicol;DOR,doripenem;DOX,doxycycline;ERT,
ertapenem;GEN,gentamicin;IPM,imipenem;LVX,levofloxacin;LMX,lomefloxacin;MPM,meropenem;MIN,minocycline;NAL,nalidixicacid;
NIT,nitrofurantoin;NOR,norfloxacin;OFX,ofloxacin;PIT,piperacillin-tazobactam;EST,streptomycin;SUL,sulphonamide;TET,tetracycline; TAC,ticarcillin-clavulanate;TRI,trimethoprim;TOB,tobramycin;SUT,trimethoprim-sulfamethoxazole.
blaCTX-M-Gp8,blaCTX-M-Gp9,blaSHV,blaPER,blaVEB,blaGES,blaKPC, blaVIM,blaOXA-48-like, blaIMP, blaSPM,blaSIM,blaGIM, andblaNDM
usingprimersandprotocolspreviouslydescribed.8–11AllPCR
wereperformedusingpositiveandnegativecontrols.
DetectionofvirulencegeneswereperformedbyPCRforthe
followinggenes:allS(allantoinmetabolism),entB,ybtSandiutA
(siderophores), kfu (iron transport and phosphotransferase
function),mrkD(adhesintype3fimbriae),rmpA(regulatorof
mucoidphenotypeA)accordingtoCompainetal.,12andycfM
(outermembranelipoprotein)andfimH(adhesivesubunitof
type1fimbriae)accordingtoElFertas-Aissanietal.13AllPCR
wereperformedusingpositiveandnegativecontrols.
Confirmation of the amplified genes’ identity was
per-formedbysequencing.Oneofeachampliconwasrandomly
selectedandpurifiedusingtheIllustraTM GFXPCRDNAand
GelBandPurificationKits(GEHealthcare,Buckinghamshire,
UK). The sequencing was performed in an automated
sequencer ABI 3500×LGeneticAnalyzer platform (Applied
Biosystems,USA).Thesequenceswereanalyzedusing
Chro-masPro version 1.7.6 software (Technelysium Pty.Ltd) and
comparedwiththe sequencesavailableinthe BLAST
algo-rithm(http://blast.ncbi.nlm.nih.gov/Blast.cgi).
EnterobacterialRepetitiveIntergenicConsensusPCR
(ERIC-PCR)analysiswasperformedtoevaluatethegeneticsimilarity
among the bacterial isolates of this study. ERIC-PCR was
performed as previously described by Versalovic et al.14
using primers ERIC1R (5-ATGTAAGCTCCTGGGGATTCAC-3)
andERIC2(5-AAGTAAGTGACTGGGGTGAGCG-3).Bandprofile
analysiswas performed usingthe BioNumerics version 5.1
program(AppliedMaths,Keistraat,Belgium)forconstruction
ofthe similaritydendrogrambythe unweightedpairgroup
mean methodand Dice’s similarity coefficient. Onlybands
representingampliconsbetween500and3000bpwere
con-sideredforthisanalysis.TheERIC-PCRassayswereperformed
intriplicatetobesureofthereproducibilityoftheamplified
bands.
Among the 14 isolates, eight (57.1%) were classified
as MDR according to the criteria established by
Magio-rakos et al.,6 being five isolates of E. cloacae (EC02, EC03,
EC04, EC05 and EC06) and three E. aerogenes (EA01, EA05
and EA06) (Fig. 1). All isolates showed non-susceptibility
(i.e. either intermediate or resistance) to sulphonamide;
12 (85.7%) isolates were non-susceptible to cefaclor and
nitrofurantoin; 11 (78.6%) to doxycycline; 11 (78.6%) to
cefixime,trimethoprim-sulfamethoxazole,trimethoprimand
nalidixic acid; nine (64.3%) to streptomycin; eight (57.1%)
to cefuroxime; six (42.9%)to lomefloxacin, ertapenem and
minocycline; five(35.7%)toceftazidime,cefepime,
ceftriax-one and piperacillin-tazobactam; four (28.6%)to amikacin,
gentamicin, tobramycin, ofloxacin, cefotaxime, aztreonam
and ticarcillin-clavulanate; three (21.43%) to ciprofloxacin,
levofloxacin, norfloxacin, doripenem and tetracycline; two
(14.3%)tomeropenemandjustoneisolate(7.14%)to
chloram-phenicol(Table1).
Theresistanceprofilefoundinthestudiedisolates
corrob-oratewithastudyconductedbyCabraletal.,4whichanalyzed
aBrazilian collectionofE.aerogenesand E.cloacae complex
isolates,andfoundthelowestresistanceratesinamikacin,
gentamicin and tobramycin. However, theyfound low
lev-elsofresistancetotrimethoprim–sulfamethoxazolewhilewe
found71.4% resistanceforthis antibiotic.Fortunately,with
the exception ofisolateEA06,all isolateswere sensitiveto
imipenem,sincepapers havedescribed thatthis antibiotic
remainsoneofthemosteffectiveincombatingE.cloacae
infec-tions.However,thereareseveralworksreportingtheadaptive
responseofclinicalisolatesofEnterobactersp.toimipenemby
regulationofporins.4,15
In this study 16 different -lactamase encoding genes
belongingtogroup2and3,accordingtoBushandJacoby16
wereinvestigated,andatotalof18ampliconsfromsix
differ-entgenes(blaCTX-M-Gp1,blaCTX-M-Gp2,blaSHV,blaVEB,blaGES,and
blaKPC)weredetected(Fig.1).Themostprevalentgenewas
Isolate EA03 EA04 EA05 EA02 EA01 EA06 EC01 EC03 EC04 EC05 EC02 EC06 EC08 EC07 RP NC NC NC NC NC NC MDR MDR MDR MDR MDR MDR MDR MDR
Blactx- Blactx- BlaSHVBlaVEBBlaGESBlaKPC MrkD Kfu EntB YbtS FimH YcfM AllS Virulence Genes found β−lactamases Gp1 Gp2 60 70 80 90 100 74.1 63.8 58.8 75.0 71.4 77.4 72.7 82.8 80.7 71.4 68.6 80.0 53.0
Fig.1–DendrogramobtainedbyenterobacterialrepetitiveintergenicconsensusPCR(ERIC-PCR)analysisofsixE.aerogenes andeightE.cloacaestudiedisolatesfromBrazil.ClustersweredeterminedusingtheUnweightedPairGroupMean(UPGMA) methodandtheDicesimilaritycoefficient.Similarity(%)amongpatternsisrepresentedbythenumbersbesidethenodes. Foreachisolatetheirrespectiveresistanceprofileclassification(RP),-lactamase(whitebars)andvirulence(blackbars) encodinggenesarerepresented.MDR,multi-drugresistant;NC,notclassified.
blaSHV,detectedin10isolates(EA01,EA03,EA04,EA05,EA06,
EC04,EC05,EC06,EC07andEC08).Thefollowinggeneswere
foundintwoisolateseachblaCTXM-Gp1(EC04andEC08),blaKPC
(EC01andEC05)andblaGES(EC06andEC08).TheblaCTX-M-Gp2
andblaVEB geneswerefoundinjustoneisolateeach (EA04
andEA01,respectively)(Fig.1).TheblaCTX-M-Gp8,blaCTX-M-Gp9,
blaPER, blaVIM, blaOXA-48-like,blaIMP, blaSPM, blaSIM,blaGIM, and
blaNDM were not detected.These results are in contrast to
thosedescribedbyCabraletal.,4whichdidnotfindbla
SHVin Entorobactersp.clinicalisolatesfromBrazil,buttheyfounda
highprevalenceofblaKPC.Inaddition,Pereiraetal.17studied
21 carbapenem-resistant E. aerogenes strains isolated from
a Braziliantertiary hospital inJuiz de Fora city located in
southeastBrazil.Theyobserved52.4%ofblaSHVand28.6%of
blaCTX-Mgroupsintheircollection.
Differentmechanismsofresistancemaybeassociatedwith
non-susceptibilityto -lactam antibioticsin Gram-negative
bacteria;howevertheenzymatic,forintrinsicandacquired
-lactamases,isthemainmechanism.16,18Amongtheisolates,
EC01andEA06presentedtheblaKPCgenebutdidnotpresent
non-susceptibility to extended-spectrum cephalosporins or
carbapenems, and the isolates EA05 and EA06 were
non-susceptibleto carbapenems and only the blaSHV gene was
detected. Therefore, the diversity of mechanisms, such as
porin loss, efflux pumpsor lack ofexpression ofacquired
genes and the presence ofother unsearched -lactamases
maybeassociatedwiththeseinconsistenciesbetweengenes
foundandexpressedphenotype.3
Ninevirulencegeneswereinvestigatedand,surprisingly,
allE.aerogenesisolatespresentedoneormoregenes,whereas
noE.cloacaeisolatepresentedvirulencegenes.Thegenetic
similarity dendrogramconstructed withthe ERIC-PCR data
showed the formation of two large clusters, denominated
AandB,comprisingthe E.aerogenesandE.cloacaeisolates,
respectively(Fig.1).TheisolateEA05presentedseven
viru-lencegenes,followedbyEA03andEA04withsix,EA06with
two,andEA01andEA02withonegene(Fig.1).Theobtained
virulenceand-lactamaseencodinggenes’sequenceswere
depositedinGenBank(www.ncbi.nlm.nih.gov/Genbank)with
accessionnumbersMF622540toMF622551.
Theresults foundsuggest apredominance of virulence
genes in E. aerogenes when compared with E. cloacae. In
additiontothefewstudies investigatingvirulencegenesin
Enterobacter sp.,19,20 to our knowledgethere are no studies
comparingthepredominanceofthesegenesinE.cloacaeandE.
aerogenes.However,asthenumberofisolatesfromthisstudy
doesnotallowestablishingastatisticalcorrelation onthis,
moredetailedstudieswithalargercollectionarerequired.
Theroleofthevirulencegenesfoundintheisolatesiswell
describedforKlebsiellapneumoniaestrains.ThegenesfimHand
mrkDencodingadhesinsoftype1and type3fimbriaeand
ycfMareoftenfoundinK.pneumoniaeandplayanimportant
roleintheprocessofbacterialadhesioninvarioushuman
tis-suesandalsointheformationofbiofilms.13 Thegeneskfu,
entBandybtSareinvolvedintheproductionofsiderophores
whichareimportantmoleculesfortheacquisitionofironfor
bacterialmetabolism.Thesesiderophores,especiallyKfu,are
oftenfoundinhypervirulentstrainsofK.pneumoniae.12 The
allSgeneassociatedwithassimilationofallantoinisclosely
associatedwithK.pneumoniaeisolatesfromliverabscesses.12
Hassanetal.19studiedthirty-twoisolatesofEnterobactersp.
obtainedfromclinicalurinespecimensandidentifiedthefimH
gene in 40% ofthe isolates. Hussainet al.21 studiedsome
virulencefactorencodinggenesof75 E.cloacaeandnine E.
sakazakiiandandobservedthatallisolateshavetheabilityto
producesiderophores.DespitetherelevanceofEnterobactersp.
asanosocomialpathogen,themechanismsofvirulenceof
thesespeciesarestillunclearduetothescarcityofstudiesin
thisarea.3
Inconclusion,ahighprevalenceofmulti-drugresistance
in the studied BrazilianEnterobacter species harboring
sev-eral-lactamaseencodinggeneswasfound.Moreover,several
virulence genes were observed in E. aerogenes, contrasting
withtheE.cloacaeisolates,whichdidnotpresent any
viru-lencegenes.Thecombinationofmulti-drugresistancewith
-lactamaseencodinggenesand associationwithvirulence
genes, especiallyin E. aerogenes, isworrying, since studies
haveshown anincreasingincidenceoftheseopportunistic
pathogenscausingnosocomialinfections.
Funding
ThisworkwassupportedbySãoPauloResearchFoundation–
FAPESP[grantnumber,2013/22581-5].
Ethical
Approval
EthicalapprovalwasreceivedfromtheSchoolof
Pharmaceu-ticalSciencesofRibeirãoPreto,UniversityofSãoPaulo,Brazil
[approvalno.:CEP/FCFRP362;CAEE36031914.9.0000.5403].
Acknowledgements
WearethankfultoDrJohannPitoutandDrAnaCristinaGales
forprovidingcontrolstrains.WealsowouldliketothankJohn
Carpenter(RibeirãoPreto,SP,Brazil)fortheEnglishrevision.
r
e
f
e
r
e
n
c
e
s
1.MezzatestaML,GonaF,StefaniS.Enterobactercloacae
complex:clinicalimpactandemergingantibioticresistance.
FutureMicrobiol.2012;7:887–902.
2.SantajitS,IndrawattanaN.Mechanismsofantimicrobial
resistanceinESKAPEpathogens.BiomedResInt.
2016;2016:2475067.
3.Davin-RegliA,PagèsJM.Enterobacteraerogenesand
Enterobactercloacae;versatilebacterialpathogensconfronting
antibiotictreatment.FrontMicrobiol.2015;18:392.
4.CabralAB,MacielMA,BarrosJF,AntunesMM,Barbosade
CastroCM,LopesAC.Clonalspreadandaccumulationof
-lactamresistancedeterminantsinEnterobacteraerogenes
andEnterobactercloacaecomplexisolatesfrominfectionand
colonizationinpatientsatapublichospitalinRecife,
Pernambuco,Brazil.JMedMicrobiol.2017;66:70–77.
5.CLSI.PerformanceStandardsforAntimicrobialSusceptibility
Testing:Twenty-SeventhInformationalSupplement.CLSI documentM100-S27.Wayne,PA:ClinicalandLaboratory
6. MagiorakosAP,SrinivasanA,CareyRB,etal.
Multidrug-resistant,extensivelydrug-resistantand
pandrug-resistantbacteria:aninternationalexpertproposal
forinterimstandarddefinitionsforacquiredresistance.Clin
MicrobiolInfect.2012;18:268–281.
7. CovoneMG,BrocchiM,PallaE,DiasdaSilveiraW,Rappuoli
R,GaleottiCL.Levelsofexpressionandimmunogenicityof
attenuatedSalmonellaentericaserovarTyphimuriumstrains
expressingEscherichiacolimutantheat-labileenterotoxin.
InfectImmun.1998;66:224–231.
8. DallenneC,DaCostaA,DecreD,FavierC,ArletG.
DevelopmentofasetofmultiplexPCRassaysforthe
detectionofgenesencodingimportantbeta-lactamasesin
Enterobacteriaceae.JAntimicrobChemother.2010;65:490–495.
9. ClímacoEC,OliveiraML,Pitondo-SilvaA,etal.Clonal
complexes104,109and113playingamajorroleinthe
disseminationofOXA-carbapenemase-producing
AcinetobacterbaumanniiinSoutheastBrazil.InfectGenetEvol.
2013;19:127–133.
10.PeiranoG,Ahamed-BentleyJ,WoodfordN,PitoutJD.New
DelhiMetallo--lactamasefromtravelerreturningto
Canada.EmerInfectDis.2011;17:240–242.
11.EllingtonMJ,KistlerJ,LivemoreDM,WoodfordN.Multiplex
PCRforrapiddetectionofgenesencodingacquired
Metallo--lactamases.JAntimicrobChemother.
2007;59:321–322.
12.CompainF,BabosanA,BrisseS,etal.MultiplexPCRfor
detectionofsevenvirulencefactorsandK1/K2capsular
serotypesofKlebsiellapneumoniae.JClinMicrobiol.
2014;52:4377–4380.
13.ElFertas-AissaniR,MessaiY,AlouacheS,BakourR.
Virulenceprofilesandantibioticsusceptibilitypatternsof
Klebsiellapneumoniaestrainsisolatedfromdifferentclinical
specimens.PatholBiol(Paris).2013;61:209–216.
14.VersalovicJ,ScheiderM,BruiknFJ,LupskiJR.Genomic
fingerpritingofbacteriausingrepetitivesequence-based
polymerasechainreaction.MetMolCellBiol.1994;5:
25–40.
15.LavigneJP,SottoA,Nicolas-ChanoineMH,BouzigesN,Pagès
JM,Davin-RegliA.AnadaptiveresponseofEnterobacter
aerogenestoimipenem:regulationofporinbalanceinclinical
isolates.IntJAntimicrobAgents.2013;41:130–136.
16.BushK,JacobyGA.Updatedfunctionalclassificationof
-lactamases.AntimicrobAgentsChemother.2010;54:
969–976.
17.PereiraRS,DiasVC,Ferreira-MachadoAB,etal.Physiological
andmolecularcharacteristicsofcarbapenemresistancein
KlebsiellapneumoniaeandEnterobacteraerogenes.JInfectDev Ctries.2016;10:592–599.
18.BushK.Bench-to-bedsidereview:theroleof
beta-lactamasesinantibiotic-resistantGram-negative
infections.CritCare.2010;14:224.
19.HassanR,El-NaggarW,El-SawyE,El-MahdyA.
Characterizationofsomevirulencefactorsassociatedwith
Enterbacteriaceaeisolatedfromurinarytractinfectionsin
MansouraHospitals.EgyptJMedMicrobiol.2011;20:15–19.
20.SouzaLopesAC,RodriguesJF,CabralAB,etal.Occurrence
andanalysisofirp2virulencegeneinisolatesofKlebsiella
pneumoniaeandEnterobacterspp.frommicrobiotaand
hospitalandcommunity-acquiredinfections.MicrobPathog.
2016;96:15–19.
21.HussainM,AlammarM.Molecularstudyofsomevirulence
factorsencodinggenesofEnterobacterspp.isolatedfrom